medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2008, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2008; 6 (4)

Facial Sweet’s syndrome secondary to unspecific chronic ulcerative colitis

Poletti ED, Muñoz SMR, García C, Kettenhofen W

Language: Spanish
References: 17
Page: 227-231
PDF size: 2056.61 Kb.


ABSTRACT

We present the case of a 42-year-old woman, who presented diverse manifestations of systemic inflammatory response syndrome: fever, odynophagia, cephalalgias, and severe facial erithema and edema. Previous digestive manifestations (abdominal pain, blood in stools) associated to important leukocytosis, skin neutrophilic infiltrations. Rectosigmoidoscopy findings allowed the diagnosis and treatment of Sweet’s syndrome secondary to unspecific chronic ulcerative colitis. We emphasized the extraintestinal manifestations that justify the search for this accompanying disease.


REFERENCES

  1. Matthews PC, Williams SM. “Sweet’s syndrome associated with systemic inflammatory response syndrome”. Intensive Care Med 1998; 24: 1106-1109.

  2. Su WPD, Liu H-NH. “Diagnostic criteria for Sweet’s syndrome”. Cutis 1986; 37: 167-170.

  3. Von den Driesch P, Schegel-Gómez RS, Kiesewetter F, Hornstein OP. “Sweet’s syndrome. Clinical spectrum and associated conditions”. Cutis 1989; 44: 193-200.

  4. Bolognia JL, Jorizzo JL, Rapini RP et al. Dermatology, 2a ed., Mosby- Elsevier, Londres, 2008, 289-295.

  5. Mensing H, Kowalzick L. “Acute febrile neutrophilic dermatosis (Sweet’s syndrome caused by minocycline)”. Dermatologica 1991;182: 43-46.

  6. Wolf, K., Goldsmith LA, Katz S, Gilchrest, I, Paller AS, Leffell DJ. Fitzpatrick’s Dermatology in general medicine, 7a ed., McGraw Hill Medical, Nueva York, 2008, 289-295.

  7. Cohen PR, Kurzrock R. “Sweet’s syndrome and cancer”. Clin Dermatol 1993; 11: 149-157.

  8. Kasper DL, Braunwald E, Fauci AS , Longo DL, Jameson JL, et al. Harrison, principios de medicina interna. 17a ed., McGraw Hill, Filadelfia, 346-349.

  9. Callen JP, Jorizzo J, Bolognia J, Piette WW y Zone JJ. Dermatological signs of internal medicine, 3a ed., Saunders, Filadelfia, 2003, 33-44 y 199- 210.

  10. Fitzgerald RL, McBurney EI, Nesbitt LT. “Sweet’s syndrome”. Int J Dermatol 1996: 35: 9-15.

  11. Fett DL, Gibson LE, Su WPD. “Sweet’s syndrome: Systemic signs and symptoms and associated disorders”. Mayo Clin Proc 1995; 70: 234- 240.

  12. Kemmet D, Hunter JAA. “Sweet’s syndrome: a clinicopathologic review of twenty-nine cases”. J Am Acad Dermatol 1990; 23: 503-507.

  13. Von der Driesch P. “Sweet’s syndrome (acute febrile neutrophilic dermatosis)”. J Am Acad Dermatol 1994; 31: 535-556.

  14. Banet DE, Callen JP, McClave SA. “Oral metronidazole, an effective treatment for Sweet’s syndrome in a patient with associated inflammatory bowel disease”. J Rheumatol 1994; 21: 1766-1768.

  15. Sweet RD. “Acute febrile neutrophilic dermatosis”. Br J Dermatol 1964; 76: 349-356.

  16. Von den Driesch PM, Djawari D, et al. “Analysis of HLA antigens in caucasian patients with acute febrile neutrophilic dermatosis (Sweet’s syndrome)”. J Am Acad Dermatol 1997: 37: 276-278.

  17. González-Guerra E, Haro R, Fariña Sabaris C, Martín Moreno L, Requena Caballero L. “Síndrome de Sweet en niños”. Piel 2008; 23 (3): 118-124.




2020     |     www.medigraphic.com